International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastases.
Meretoja TJ, Audisio RA, Heikkilä PS, Bori R, Sejben I, Regitnig P, Luschin-Ebengreuth G, Zgajnar J, Perhavec A, Gazic B, Lázár G, Takács T, Kővári B, Saidan ZA, Nadeem RM, Castellano I, Sapino A, Bianchi S, Vezzosi V, Barranger E, Lousquy R, Arisio R, Foschini MP, Imoto S, Kamma H, Tvedskov TF, Jensen MB, Cserni G, Leidenius MH.
Meretoja TJ, et al. Among authors: imoto s.
Breast Cancer Res Treat. 2013 Apr;138(3):817-27. doi: 10.1007/s10549-013-2468-3. Epub 2013 Apr 5.
Breast Cancer Res Treat. 2013.
PMID: 23558360
Clinical Trial.